181 related articles for article (PubMed ID: 12522485)
1. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum.
Sun F; Tai S; Lim T; Baumann U; King M
Can Respir J; 2002; 9(6):401-6. PubMed ID: 12522485
[TBL] [Abstract][Full Text] [Related]
2. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
Dasgupta B; King M
Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
[TBL] [Abstract][Full Text] [Related]
3. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
Feng W; Garrett H; Speert DP; King M
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
[TBL] [Abstract][Full Text] [Related]
4. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
King M; Dasgupta B; Tomkiewicz RP; Brown NE
Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
[TBL] [Abstract][Full Text] [Related]
5. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis.
Homnick DN; Marks JH; Rubin BK
J Aerosol Med; 2007; 20(1):45-9. PubMed ID: 17388752
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
7. Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis.
App EM; Baran D; Dab I; Malfroot A; Coffiner M; Vanderbist F; King M
Eur Respir J; 2002 Feb; 19(2):294-302. PubMed ID: 11866009
[TBL] [Abstract][Full Text] [Related]
8. Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro.
Rubin BK; Kater AP; Goldstein AL
Chest; 2006 Nov; 130(5):1433-40. PubMed ID: 17099021
[TBL] [Abstract][Full Text] [Related]
9. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
Shibuya Y; Wills PJ; Cole PJ
Respiration; 2001; 68(6):615-9. PubMed ID: 11786718
[TBL] [Abstract][Full Text] [Related]
10. Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler in dogs: airway epithelial function changes.
Tomkiewicz RP; App EM; Coffiner M; Fossion J; Maes P; King M
Eur Respir J; 1994 Jan; 7(1):81-7. PubMed ID: 8143836
[TBL] [Abstract][Full Text] [Related]
11. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.
Tomkiewicz RP; App EM; De Sanctis GT; Coffiner M; Maes P; Rubin BK; King M
Pulm Pharmacol; 1995 Dec; 8(6):259-65. PubMed ID: 8819180
[TBL] [Abstract][Full Text] [Related]
12. Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
Shibuya Y; Wills PJ; Cole PJ
Respirology; 2003 Jun; 8(2):181-5. PubMed ID: 12753533
[TBL] [Abstract][Full Text] [Related]
13. Physical and transport properties of sputum from children with idiopathic bronchiectasis.
Redding GJ; Kishioka C; Martinez P; Rubin BK
Chest; 2008 Dec; 134(6):1129-1134. PubMed ID: 18753467
[TBL] [Abstract][Full Text] [Related]
14. Effects of dextran sulfate on tracheal mucociliary velocity in dogs.
Sudo E; Boyd WA; King M
J Aerosol Med; 2000; 13(2):87-96. PubMed ID: 11010598
[TBL] [Abstract][Full Text] [Related]
15. Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.
Broughton-Head VJ; Shur J; Carroll MP; Smith JR; Shute JK
Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1240-9. PubMed ID: 17827252
[TBL] [Abstract][Full Text] [Related]
16. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.
Rubin BK
Chest; 1999 Jul; 116(1):195-200. PubMed ID: 10424525
[TBL] [Abstract][Full Text] [Related]
17. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.
Bush A; Payne D; Pike S; Jenkins G; Henke MO; Rubin BK
Chest; 2006 Jan; 129(1):118-23. PubMed ID: 16424421
[TBL] [Abstract][Full Text] [Related]
18. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4.
Kater A; Henke MO; Rubin BK
Ann N Y Acad Sci; 2007 Sep; 1112():140-53. PubMed ID: 17496063
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus.
Zahm JM; Girod de Bentzmann S; Deneuville E; Perrot-Minnot C; Dabadie A; Pennaforte F; Roussey M; Shak S; Puchelle E
Eur Respir J; 1995 Mar; 8(3):381-6. PubMed ID: 7789481
[TBL] [Abstract][Full Text] [Related]
20. Is cystic fibrosis mucus abnormal?
King M
Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
